Physician profile
Anil Birdi
NPI 1598022873
$6,741.86
in general payments reported to CMS, 2019-2025
25 companies · $685 in 2025
The $685 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,738 · 2020: $368 · 2021: $263 · 2022: $1,646 · 2023: $509 · 2024: $533 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $3,068.24 | 2019-2025 | Tecnis Iol, Catalys System, Tecnis Iol |
| New World Medical,INC. | $844.09 | 2022-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Alcon Vision LLC | $778.90 | 2019-2025 | Clareon, Hydrus Microstent, Rocklatan |
| Ocular Therapeutix, INC. | $234.86 | 2019-2023 | Dextenza |
| Oyster Point Pharma, INC. | $230.62 | 2022-2025 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $207.77 | 2022-2025 | Miebo, Xiidra, Envista Mx60 Iol |
| Biotissue Holdings INC. | $205.94 | 2020-2025 | |
| Rxsight INC | $200.50 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Allergan, INC. | $175.08 | 2020-2022 | |
| Ivantis, INC | $150.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $120.33 | 2019-2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $81.54 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $74.98 | 2025 | Xdemvy |
| Sight Sciences, INC. | $60.39 | 2020-2022 | |
| Dompe US, INC. | $53.06 | 2024-2025 | Oxervate |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $51.26 | 2023-2024 | Rayone Emv, Rayone Aspheric, Omidria |
| Abbvie INC. | $42.86 | 2022-2025 | Durysta |
| Glaukos Corporation | $36.81 | 2025 | Idosetr |
| Mallinckrodt Hospital Products INC. | $32.46 | 2021-2023 | Acthar |
| Omeros Corporation | $18.64 | 2021 | |
| Kala Pharmaceuticals, INC. | $17.33 | 2021 | |
| Harrow Eye, LLC | $17.00 | 2024 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.37 | 2019 | |
| Akorn, INC. | $14.31 | 2020 | |
| Iridex Corporation | $10.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Birdi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.